Myasthenia Gravis Research
The goal of myasthenia gravis research is to increase scientific understanding of the disorder, learn what causes the autoimmune response in the disorder, and better define the relationship between the thymus gland and myasthenia gravis. Scientists are currently evaluating new treatments such as the effectiveness of intravenous immune globulin in patients with myasthenia gravis. In order to improve current treatments, researchers are also seeking a better understanding of the molecular basis of synaptic transmission in the nervous system.
In recent years, technological advances have led to:
- More timely and accurate myasthenia diagnoses
- New and enhanced treatment for myasthenia gravis, which has improved the management of the disorder
- Knowledge about the structure and function of the neuromuscular junction
- Knowledge about the fundamental aspects of the thymus gland
- Specific knowledge about myasthenia gravis and a better general understanding of other autoimmune disorders.
However, despite these advances, there is still much to learn. The goals of myasthenia gravis research are to:
- Increase scientific understanding of the disorder
- Learn what causes the autoimmune response in myasthenia gravis
- Better define the relationship between the thymus gland and myasthenia gravis.
Research scientists are currently evaluating new treatments and improving current treatments for myasthenia gravis.
One research study is testing the effectiveness of intravenous immune globulin in patients with myasthenia gravis. The goal of the study is to determine whether this treatment safely improves muscle strength. Another myasthenia gravis research study seeks further understanding of the molecular basis of synaptic transmission in the nervous system. The objective of this study is to expand current knowledge of the function of receptors and to apply this knowledge to myasthenia gravis treatment.